Dr Efstathiou on the Evolution of Trimodal Therapy in MIBC
Jason Efstathiou, MD, DPhil, discusses the utility of trimodal therapy in patients with muscle-invasive bladder cancer.
United States Jason Efstathiou Harvard Medical School John Bertucci Center National Comprehensive Cancer Network Faculty Academic Affairs
Source: onclive.com